— Know what they know.
Not Investment Advice

IGMS NASDAQ

IGM Biosciences, Inc.
1W: +0.0% 1M: +0.0% 3M: +10.4% 1Y: -85.7% 3Y: -95.1% 5Y: -97.7%
$1.27
Last traded 2025-08-15 — delisted
NASDAQ · Healthcare · Biotechnology · $77.5M mcap · 29M float · 2.16% daily turnover · Short 28% of daily vol

📊 Key Metrics

TTM
$145M
Revenue
+4882.8% YoY
$-53M
Net Income
+75.8% YoY
$-159M
Free Cash Flow
+9.9% YoY
99.7%
Gross Margin
90.7%
Op. Margin
67.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-47.8%
ROA-24.1%
ROIC651.8%

Valuation

P/E-0.4
P/B1.6
EV/EBITDA1.1

Leverage

Debt/Equity0.00
Current Ratio17.66
Interest Cov.0.0x

Quality Scores

Piotroski F5/9
Altman Z-4.58
Beneish M101.41

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms